Efficacy of Sacubitril/Valsartan for the Treatment of Heart Failure with Moderately Reduced and Preserved Ejection Fraction

Heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction are associated with significant morbidity and mortality, as well as growing economic burden. This review describes recent studies on the use of sacubitril/valsartan in heart failure patients with mildly reduced or preserved ejection fraction.